92 related articles for article (PubMed ID: 16079091)
1. Rationale for dendritic cell-based vaccines for acute myeloid leukemia.
Biragyn A
Haematologica; 2005 Aug; 90(8):1010C. PubMed ID: 16079091
[No Abstract] [Full Text] [Related]
2. Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro.
Delluc S; Tourneur L; Michallet AS; Boix C; Varet B; Fradelizi D; Guillet JG; Buzyn A
Haematologica; 2005 Aug; 90(8):1050-62. PubMed ID: 16079104
[TBL] [Abstract][Full Text] [Related]
3. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
[TBL] [Abstract][Full Text] [Related]
4. DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method.
Delluc S; Tourneur L; Fradelizi D; Rubio MT; Marchiol-Fournigault C; Chiocchia G; Buzyn A
Cancer Immunol Immunother; 2007 Jan; 56(1):1-12. PubMed ID: 16676183
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
6. Peptide vaccines for patients with acute myeloid leukemia.
Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A
Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762
[TBL] [Abstract][Full Text] [Related]
7. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.
Röhn TA; Reitz A; Paschen A; Nguyen XD; Schadendorf D; Vogt AB; Kropshofer H
Cancer Res; 2005 Nov; 65(21):10068-78. PubMed ID: 16267033
[TBL] [Abstract][Full Text] [Related]
9. Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia.
Klammer M; Roddie PH
Expert Rev Vaccines; 2006 Apr; 5(2):211-22. PubMed ID: 16608421
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapeutic efficacy of both helper T lymphocytes and cytotoxic T lymphocytes epitopes augmented dendritic cells tumor vaccine on gastric cancer].
Li Q; Zhang Y; Chen XH; Cao WX; Gu QL; Zhu ZG; Liu BY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):148-51. PubMed ID: 16555158
[TBL] [Abstract][Full Text] [Related]
11. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library.
Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G
Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836
[TBL] [Abstract][Full Text] [Related]
12. Fusion of dendritic cells and CD34+CD38- acute myeloid leukemia (AML) cells potentiates targeting AML-initiating cells by specific CTL induction.
Lei Z; Zhang GM; Hong M; Feng ZH; Huang B
J Immunother; 2009 May; 32(4):408-14. PubMed ID: 19342964
[TBL] [Abstract][Full Text] [Related]
13. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
Kim EK; Cho HI; Yoon SH; Park MJ; Sohn HJ; Kim HJ; Oh ST; Kim TG
Vaccine; 2008 Jul; 26(32):3987-97. PubMed ID: 18584926
[TBL] [Abstract][Full Text] [Related]
14. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
[TBL] [Abstract][Full Text] [Related]
15. Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts.
Jandus C; Bioley G; Dojcinovic D; Derré L; Baitsch L; Wieckowski S; Rufer N; Kwok WW; Tiercy JM; Luescher IF; Speiser DE; Romero P
Cancer Res; 2009 Oct; 69(20):8085-93. PubMed ID: 19808957
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities.
Yu Z; Ren P; Zhang X; Zhang T; Ma B
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1065-71. PubMed ID: 19671026
[TBL] [Abstract][Full Text] [Related]
17. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
18. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 kick-starts T helper 1 cell differentiation.
Malefyt Rde W
Immunity; 2009 Nov; 31(5):700-2. PubMed ID: 19932069
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccines in acute leukaemia.
Duncan C; Roddie H
Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
